A Randomized Controlled Trial of sublingual versus extended-release buprenorphine with individuals leaving Carceral Settings Grant uri icon

Overview

date/time interval

  • October 1, 2022 - April 30, 2024

sponsor award ID

  • 3 UG1 DA050077-04S1

Affiliation